240 related articles for article (PubMed ID: 2675634)
21. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of vanadyl sulfate on skin injury in streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Hum Exp Toxicol; 2013 Nov; 32(11):1206-12. PubMed ID: 24281993
[TBL] [Abstract][Full Text] [Related]
23. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; McNeill JH
Pharmacol Toxicol; 1994 Feb; 74(2):101-9. PubMed ID: 8190697
[TBL] [Abstract][Full Text] [Related]
24. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects.
Domingo JL; Gómez M; Llobet JM; Corbella J; Keen CL
Pharmacol Toxicol; 1991 Apr; 68(4):249-53. PubMed ID: 1866388
[TBL] [Abstract][Full Text] [Related]
25. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
[TBL] [Abstract][Full Text] [Related]
26. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
27. Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats.
Thompson KH; McNeill JH
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):187-200. PubMed ID: 8100638
[TBL] [Abstract][Full Text] [Related]
28. Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats.
Sarangarajan R; Cacini W
Pharmacol Toxicol; 1999 Oct; 85(4):169-73. PubMed ID: 10563515
[TBL] [Abstract][Full Text] [Related]
29. Effects of oral vanadyl treatment on diabetes-induced alterations in the heart GLUT-4 transporter.
Kopp SJ; Daar J; Paulson DJ; Romano FD; Laddaga R
J Mol Cell Cardiol; 1997 Sep; 29(9):2355-62. PubMed ID: 9299359
[TBL] [Abstract][Full Text] [Related]
30. Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats.
Kurt O; Ozden TY; Ozsoy N; Tunali S; Can A; Akev N; Yanardag R
Biometals; 2011 Oct; 24(5):943-9. PubMed ID: 21479831
[TBL] [Abstract][Full Text] [Related]
31. Effects of vanadyl sulfate on kidney in experimental diabetes.
Yanardag R; Bolkent S; Karabulut-Bulan O; Tunali S
Biol Trace Elem Res; 2003 Oct; 95(1):73-85. PubMed ID: 14555801
[TBL] [Abstract][Full Text] [Related]
32. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R; Giridhar R; Yadav MR
J Trace Elem Med Biol; 2005; 18(3):211-7. PubMed ID: 15966569
[TBL] [Abstract][Full Text] [Related]
33. Concentration-dependent glucose-lowering effects of oral vanadyl are maintained following treatment withdrawal in streptozotocin-diabetic rats.
Cam MC; Faun J; McNeill JH
Metabolism; 1995 Mar; 44(3):332-9. PubMed ID: 7885278
[TBL] [Abstract][Full Text] [Related]
34. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
Dehghani GA; Ahmadi S; Omrani GR
Indian J Med Res; 1997 Nov; 106():481-5. PubMed ID: 9415745
[TBL] [Abstract][Full Text] [Related]
35. Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.
Anand-Srivastava MB; McNeill JH; Yang XP
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):113-9. PubMed ID: 8927025
[TBL] [Abstract][Full Text] [Related]
36. Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats.
Thompson KH; Leichter J; McNeill JH
Biochem Biophys Res Commun; 1993 Dec; 197(3):1549-55. PubMed ID: 8280174
[TBL] [Abstract][Full Text] [Related]
37. Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used.
Domingo JL; Gomez M; Llobet JM; Corbella J; Keen CL
Toxicology; 1991 Mar; 66(3):279-87. PubMed ID: 1826377
[TBL] [Abstract][Full Text] [Related]
38. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
39. Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; Vera E; McNeill JH
Pharmacol Toxicol; 1994 Nov; 75(5):265-73. PubMed ID: 7870697
[TBL] [Abstract][Full Text] [Related]
40. [Comparative characteristics of vanadium-containing compounds, possessing insulin-like effects].
Golubev MA; Gorodetskiĭ VK; Anis'kina AP; Tochilkin AI; Beliaeva NF
Vopr Med Khim; 2000; 46(2):155-61. PubMed ID: 10885036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]